| BRIEF REPORT |
|
| Year : 2007 | Volume
: 55
| Issue : 1 | Page : 75-76 |
|
|
Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity
Parag K Shah1, V Narendran1, Khaled A Tawansy2, A Raghuram1, Kalpana Narendran3
1 Vitreo-Retinal Services, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India
2 Children's Retina Institute of California, Glendale, USA
3 Pediatric Ophthalmology Services, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India
Correspondence Address:
Parag K Shah
Department of Vitreous and Retina, Aravind Eye Hospital, Avinashi Road, Coimbatore - 641 014, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0301-4738.29505
|
|
|
Aggressive posterior retinopathy of prematurity (formerly known as fulminate/type II/rush disease) occurs in zone 1 or posterior zone 2. Treatment involves extensive near confluent laser ablation of a large area of avascular retina. Anterior segment ischemia is a rare complication that can occur due to injury to the long posterior ciliary arteries in the horizontal meridians during aggressive posterior laser treatment. The outcome of this rare complication is very poor. This case describes a favorable outcome of intravitreal injection of bevacizumab (Avastin) in a case of anterior segment ischemia. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
.png "Santen")
